Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) 33.3% HIGHER; announced the recent publication of a new scientific paper further supporting Hedgehog signaling pathway inhibition as a promising new approach to treat cancer. Click here for the full report.

J. Crew Group, Inc. (NYSE: JCG) 18.1% HIGHER; reports Q1 EPS of $0.32, versus the analyst estimate of $0.11. Revenue for the quarter was $345.8 million, versus the consensus of $322.11 million. Same store sales fell 5% during the quarter. Sees Q2 EPS of $0.08-$0.12, versus the consensus of a loss of $0.02.

Jamba, Inc. (NASDAQ: JMBA) 16.7% LOWER; reports a Q1